Aerovate Therapeutics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
Jade Biosciences filed a Form S-1 to register 3.21 million shares for resale from its December 2025 $45 million PIPE, with no proceeds to the company.
Jade Biosciences, a clinical-stage biopharmaceutical company, filed an S-1 registration statement for the resale of 16.1 million common shares by selling stockholders, following a $135 million private placement and a reverse merger.